FOMX - Foamix Pharmaceuticals Ltd.
Previous close
2.99
0 0%
Share volume: 0
Last Updated: Fri 06 Mar 2020 06:00:00 AM CET
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$2.99
0.00
0.00%
Summary score
29%
Profitability
35%
Dept financing
8%
Liquidity
41%
Performance
26%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.79%
Return on assets
-20.65%
Return on sales
-1475.04%
Return on invested capital
-187.47%
Total debt ratio
17.82%
Debt ratio change over timeo
-0.97%
Current Ratio
10.74%
Quick Ratio
2.56%
Cash Position Ratio
3.97%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-77.35%
Return on assets
-29.42%
Return on sales
0%
Return on invested capital
233.01%
Total debt ratio
36.61%
Debt ratio change over timeo
-0.85%
Current Ratio
5.61%
Quick Ratio
2.56%
Cash Position Ratio
2.35%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-215.19%
Return on assets
-46.12%
Return on sales
0%
Return on invested capital
153.86%
Total debt ratio
78.34%
Debt ratio change over time
-0.72%
Current Ratio
2.61%
Quick Ratio
2.56%
Cash Position Ratio
1.52%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-106.3%
Return on assets
-101.34%
Return on sales
254.81%
Return on invested capital
128.42%
Total debt ratio
-97.14%
Debt ratio change over time
-0.97%
Current Ratio
-4.49%
Quick Ratio
-0.08%
Cash Position Ratio
-2.25%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | FOMX | MYOK | MDCO | ARQL |
---|---|---|---|---|
Return on equity | -35.79% | -6.14% | -82.7% | -26.35% |
Return on assets | -20.65% | -5.6% | -6.39% | -11.28% |
Return on sales | -1475.04% | 0% | -592.81% | 0% |
Return on invested capital | -187.47% | -77.12% | -39.78% | 65.12% |
Profitability | 0% | 75% | 0% | 25% |
Total debt ratio | 17.82% | 15.04% | 89.22% | 36.77% |
Debt ratio change over time | -0.97% | -0.99% | -8.16% | -0.59% |
Dept financing | 5% | 4% | 25% | 35% |
Current Ratio | 5.61% | 14.83% | 3.61% | 9.09% |
Quick Ratio | 2.56% | 0% | 4.07% | 0% |
Cash Position Ratio | 2.35% | 10.32% | 2.93% | 3.8% |
Liquididy | 64% | 45% | 39% | 23% |
Short-term ratios | FOMX | MYOK | MDCO | ARQL |
---|---|---|---|---|
Return on equity | -77.35% | -9.04% | 15.39% | -9.03% |
Return on assets | -29.42% | -8.8% | -5.77% | -7.25% |
Return on sales | 0% | 0% | 0% | 0% |
Return on invested capital | 233.01% | 40.09% | -24.53% | 48.27% |
Profitability | 50% | 4% | 50% | 5% |
Total debt ratio | 36.61% | 6.99% | 103.89% | 18.86% |
Debt ratio change over time | -0.85% | -1.1% | -10.95% | -0.73% |
Dept financing | 9% | 2% | 25% | 30% |
Current Ratio | 5.61% | 14.83% | 3.61% | 9.09% |
Quick Ratio | 2.56% | 0% | 4.07% | 0% |
Cash Position Ratio | 2.35% | 10.32% | 2.93% | 3.8% |
Liquididy | 31% | 50% | 38% | 25% |